to predict a poor response to chemotherapy in acute myeloid leukaemia and ovarian carcinoma. We describe the cloning and chromosome localization of the gene coding for this novel protein. The deduced LRP amino acid sequence shows 87.7% identity with the 104-kD rat major vault protein. Vaults are multi-subunit structures that may be involved in nucleo-cytoplasmic transport. The LRP gene is located on chromosome 16, close to the genes coding for multidrug resistance-associated protein and protein kinase C-~, and may mediate drug resistance, perhaps via a transport process.
Multidrug-resistant cancer cells frequently overexpress the 110-kD LRP protein (originally named lung Resistance-related Protein). LRP overexpression has been found
to predict a poor response to chemotherapy in acute myeloid leukaemia and ovarian carcinoma. We describe the cloning and chromosome localization of the gene coding for this novel protein. The deduced LRP amino acid sequence shows 87.7% identity with the 104-kD rat major vault protein. Vaults are multi-subunit structures that may be involved in nucleo-cytoplasmic transport. The LRP gene is located on chromosome 16, close to the genes coding for multidrug resistance-associated protein and protein kinase C-~, and may mediate drug resistance, perhaps via a transport process.
The effectiveness of chemotherapy is often hampered by intrinsic or acquired drug resistance of the tumour cells. Most common malignancies already show a poor response to chemotherapy during initial treatment. Some initially respond favourably to chemotherapy, but subsequently develop multidrug resistance'. Transmembrane transporter molecules, notably P-glycoprotein (Pgp)' or the multidrug resistance-associated protein (MRP)'·', can mediate such drug resistance by acting as cytotoxic drug efflux pumps. Even so, multidrug-resistant (MDR) tumour cell lines have been described without overexpression of either Pgp or MRP (refs 5, 6, 7) , indicating that other mechanisms may be operative.
We reported recently on the production of the mouse monoclonal antibody LRP-56, which detects a 110-kD protein that we have named Lung Resistance-related Protein (LRP), because it was first identified in an MDR lung cancer cell line". LRP has been found to be overexpressed in all non-Pgp MDR tumour cell lines examined thus far, including the SW1573/2R120 (lung cancer), MCF-7/MITOX (breast cancer), HT10SO/DR4 (fibrosarcoma) and S226/MR40 (myeloma) cell lines•. Further support for a close association of LRP with a resistant phenotype was obtained by the observation that reversal of drug resistance in the SW1573/2R120 tumour cell line was accompanied by a subsequent decrease in expression of the protein". Moreover, LRP expression in acute myeloid leukaemia" and in advanced ovarian carcinoma'" was found to have a high predictive value for poor response to chemotherapy and adverse clinical outcome.
Molecular characterization of this novel gene is of crucial importance for further investigations into its role and the mechanism of action of its product in normal tissues and in 578 multidrug resistance. To this end, a eukaryotic expression system was used to isolate a full-length complementary DNA (eDNA) clone encoding LRP. The eDNA was sequenced and scanned for homology with other sequences. Isotopelabelled RNA probes were generated to detect the levels of the cognate RNA in MDR cell lines, and the chromosome localization of LRP was revealed by fluorescence in situ hybridization (FISH).
eDNA isolation and protein precipitation
The eDNA coding for the LRP gene product was isolated by expression cloning using mouse MOPS cells and the LRP-56 monoclonal antibody to screen a eDNA library derived from the human non-Pgp multidrug-resistant fibrosarcoma cell line HT10SO/DR4. Purified pCDMS plasmids containing eDNA inserts where transfected into MOPS cells and octo-cytospin preparations were screened for transiently expressed protein with the LRP-56 monoclonal antibody. The colony containing the LRP eDNA insert was isolated by screening progressively smaller pools of bacterial colonies ( Fig. 1 ). Confirmation of the isolation of full-length eDNA was obtained by "S-immunoprecipitation. From both control MDR tumour cells and LRPtransfected MOPS cells, but not from MOPS cells transfected with irrelevant plasmid, the predicted M, 110K protein was precipitated ( Fig. 2 ). No precipitated protein was observed when the LRP-56 monoclonal antibody was replaced by an irrelevant antibody (data not shown).
eDNA sequence and mRNA expression
The eDNA was digested by restriction enzymes and subcloned in pBluescript SKII+. Sequence analysis of the full-length insert and subcloned fragments was performed to obtain the complete eDNA sequence. The sequence displays a single open reading frame of 2,688 base pairs coding for an 896-amino acid protein with a calculated M, of lOOK. A computer-assisted search of the LRP eDNA versus the GenBank library revealed a very high level of similarity with the sequences coding for the major vault proteins (MVP) from Dictyostelium discoideum and Rattus norvegicus"· 12 • MVP accounts for more than 70% of the composition of rat vaults". Alignment of the deduced protein sequences of LRP and MVP-a from the slime mould D. discoideum, consisting of 896 and 843 amino acids, respectively, showed that 57% of the amino acids were identical. Alignment of LRP and MVP from R. norvegicus (895 amino acids), showed that 87.7% of the amino acids (785) are identical ( Fig. 3) . Like MVP-a from D. discoideum, the LRP sequence lacks the additional ten amino acids at the amino terminus. This supports the view that in the rat the second methionine is used as the authentic translation start".
To study the correlation between LRP protein and messenger RNA expression, a 232-nucleotide Apal fragment of the LRP eDNA sequence was selected to produce an isotopelabelled probe for RNase protection assays. Cytoplasmic RNA of MDR cell lines was isolated and tested for LRP mRNA levels. LRP mRNA in the non-Pgp MDR tumour cell line SW1573/2R120 is approximately 8 and 4 times as high as the SW1573/ZR160, a Pgp-positive MDR subline with low LRP expression, and SW1573/2R120 partial revertant, respectively. LRP mRNA in the MDR subline GLC4-ADR is approximately 14 times as high as in the drug-sensitive parental cell line GLC4-S (Fig. 4) .
The full-length LRP eDNA was cloned into the eukaryotic expression vector pRc/CMV. Stable LRP-transfectants of the drugsensitive A2780 ovarian carcinoma cell line that expressed significant levels of the LRP protein were obtained. These transfectants did not show increased resistance to doxorubicin, vincristine or VP16 as compared with untransfected A2780 cells (data not shown).
FISH localization
The complete LRP eDNA insert was biotin labelled for fluorescence in situ hybridization to normal human metaphases.
Using a reference probe for the 16qter telomeric region (Oncor, P-5432), the LRP gene was found to be localized to the short arm of chromosome 16, within the 16p13.1-16p11.2 chromosomal region ( Fig. 5 ).
Discussion

Major vault protein structure
The almost complete identity of the amino acid sequence of the human LRP protein and the rat major vault protein proves conclusively that LRP is the human major vault protein. Vaults were discovered by Kedersha and Rome in 1986 when electron microscopy showed small ovoid bodies in rat liver vesicle preparations"·". The cellular organelles are ribonucleoprotein particles containing four proteins of M, 210K, 192K, 104K and 54K, respectively, and a species of small RNA of ~140 bases in the relative molar ratios of 3:1:55*:7:9 (*MVP: the LRP homologue). The particles measure approximately 35 x 65 nm, have a total mass of 13 MD, and are shaped as hollow, barrellike structures with 822 symmetry, being composed of two identical cup-like halves joined at their open ends".
Because vaults have been found in cells from amoebas to humans and have apparently been very well preserved throughout evolution, they are expected to play a key role in fundamental cell processes"·" . Although a precise tissue distribution of vaults is not available, vaults have been reported to be most abundant in epithelial cells and macrophages 1 '. We found LRP to be present in most normal human tissues, and highest expression was observed in epithelial cells with secretory and excretory functions, as well as in cells chronically exposed to xenobiotics, such as bronchial cells and cells lining the intestine•. Acute myeloid leukaemic patients with a deletion of one of the MRP genes, resulting from a chromosome 16 inversion, were reported to have a favourable outcome 20 • We are currently investigating such patients for the presence of a further LRP deletion, which could contribute to or even account for this favourable outcome, as suggested by the prognostic value of LRP expression in patients with acute myeloid leukaemia.
The above-mentioned studies in leukaemia•, ovarian carci-noma10 and in the unselected human cancer cell lines provided evidence that MRP and LRP expression are not co-regulated. Although LRP and MRP were frequently coexpressed, many specimens showed high expression of only one of the two molecules, with low or no expression of the other. Apparently, the two genes, though located close to each other, can be switched on individually and relate independently to the MDR phenotype.
Major vault protein function
The function of vaults is still far from clear. Approximately 5% of the vaults are nucleus associated and localize to the nuclear pore complexes 21 . Nuclear pore complexes are multicomponent structures that allow a bidirectional nucleo-cytoplasmic exchange of molecules and particles 22 • Vaults are thought to constitute the transporters or central plugs of the nuclear pore complexes, controlling this exchange 14 ' 21 . The majority of vaults, however, have a cytoplasmic localization and were originally isolated in association with vesicular structures 13 . The coarsely granular, cytoplasmic staining pattern observed with the LRP-56 monoclonal antibody also suggests a vesicular localization for LRP'. LRP and/or vaults may regulate nucleocytoplasmic as well as vesicular transport of different substrates, including cytotoxic drugs. In support of this view, the decreased nucleus/cytoplasm ratio of drugs and sequestration of drugs in exocytotic vesicles has been reported in LRPoverexpressing MDR celllines 23
To further elucidate the contribution of the LRP gene product and vaults to cell physiology and multidrug resistance, we have produced stable LRP gene transfectants. Initial results of drug sensitivity testing with these transfectants indicate that transfection with just the LRP gene itself is insufficient to confer a MDR phenotype. Considering that the assembled functional vault structure is a multi-subunit particle, consisting of LRP/MVP and at least three other proteins as well as an RNA moiety, other approaches need to be explored. We are currently investigating the possibility of disrupting the assembling of functional vaults with LRP hammerhead ribozymes and examining what effect this will have on multidrug resistance.
In conclusion, the sequence and the chromosome localization of the novel and highly conserved human LRP gene is described. The evolutionary preservation of this major vault protein gene predicts a prominent physiological function. Its frequent upregulation in MDR tumour cells together with its value in predicting in vitro and clinical response to chemotherapy support the view that LRP and/or vaults can, next to members of the transmembrane transporter family, contribute to cytostatic drug resistance. . and an oligo dT column. A size-fractionated (>2,000 bp) oligo dTprimed eDNA library was constructed in a pCDM8 vector using nonself complementary BstXI linkers. High-voltage electroporation (25 jlF, 200 ohm, 2.5 kV em-') of the library into the Escherichia coli strain MC1061/p3 yielded approximately 100,000 primary colonies. These were divided into ten sublibraries of 10,000 colonies each. 32 , by using T7 polymerase and "S-Iabelled nucleotides. Bands were revealed by autoradiography. lmmunoprecipitation assay. MOPS cells, 24 hours after transfection with LRP or irrelevant plasm ids, and MDR control cells were used in the immunoprecipitation assay as previously described•. Cells were labelled overnight with 4 ~tCi ml·' ["S]methionine. Equal counts per minute (25 X 1 0 6 /sample) of clear supernatants were precipitated with 1 0 llg of LRP-56 mAb or 1 0 ~J.g of irrelevant mAb. Precipitated protein was shown by autoradiography: RNase protection assay. RNase protection assay was performed as described". Cytoplasmic RNA of the cell lines (1 0 ~J.g) was hybridized with a-32 P-Iabelled RNA transcripts complementary to LRP mRNA sequences or y-actin. The LRP probe was transcribed from fcoRI-Iinearized DNA from a LRP-Apal fragment (nucleotides 2,326-2,558) in pBiuescript using T7 RNA polymerase. The DNA template was removed by DNase I treatment. After RNase A treatment, protected probe was visualized by electrophoresis through a denaturing 6% acrylamide gel, followed by autoradiography. Stable transfectants and chemosensitivity testing. LRP fulllength eDNA was cloned into the eukaryotic expression vector pRc/CMV (Invitrogen). A2780 cells were transfected with 5 llg of purified plasmid by calcium phosphate precipitation•. Stable transfectants were selected for three weeks in medium containing 800 ~J.g ml·' G418 (ref. 4). Transfectants were tested for expression of LRP protein by immunohistochemistry. Resistance of stable LRP transfectants to doxorubicin, vincristine and VP16 was determined by ['H]thymidine incorporation after a 3-day culture period in different concentrations of drug. Untransfected A2780 cells were used as a control. SW1573/2R120 MDR cells were used as a positive control. FISH. Full-length LRP eDNA was biotin-labelled by nick translation (Boehringer nick-translation kit). Slides containing metaphases were treated per manufacturer's instructions for the Oncor chromosome in situ hybridization system for single-copy sequence detection in metaphase chromosomes using fluorescein isothiocyanate-labelled avidin/anti-avidin antibody for amplification of the signal. A digoxigenin-labelled cosmid probe specific for the 1 6qter telomeric region (Oncor, P-5432), detected with rhodamine-anti-digoxigenin, was used as a reference probe. Metaphase analysis and photomicroscopy
